Table 2. Population, patients, drug recipients, defined daily doses, and annual changes, FY 2010–2012.

	Number			Annual change (%)
	2010	2011	2012	Year to year		Average
				2011	2012
Population
All age groups	3,493,783	3,505,251	3,517,835	0.3%	0.4%	0.3%
Adults and elderly (≥ 15 years)	2,675,651	2,695,613	2,723,356	0.7%	1.0%	0.9%
Elderly (≥ 60 years)	501,128	516,310	536,182	3.0%	3.8%	3.5%
Patients ≥ 15 years
Diabetes	117,307	121,425	126,859	3.5%	4.5%	4.1%
Cardiovascular diseases	294,751	311,685	329,859	5.7%	5.8%	6.0%
Patients per 1,000 population
Diabetes	43.8	45.0	46.6	2.7%	3.4%	3.1%
Cardiovascular diseases	110.2	115.6	121.1	5.0%	4.8%	5.0%
Drug recipients
Antidiabetics	81,978	90,558	96,938	10.5%	7.0%	9.1%
Antidiabetics, oral	73,766	81,586	87,200	10.6%	6.9%	9.1%
Antihypertensive agents	139,311	168,485	186,279	20.9%	10.6%	16.9%
Antilipidemics	119,193	148,578	170,281	24.7%	14.6%	21.4%
Drug recipients per 1,000 population
Antidiabetics	30.6	33.6	35.6	9.6%	6.0%	8.1%
Antidiabetics, oral	27.6	30.3	32.0	9.8%	5.8%	8.1%
Antihypertensive agents	52.1	62.5	68.4	20.0%	9.4%	15.7%
Antilipidemics	44.5	55.1	62.5	23.7%	13.4%	20.2%
Drug recipients per 100 patients
Antidiabetics	69.9	74.6	76.4	6.7%	2.5%	4.7%
Antidiabetics, oral	62.9	67.2	68.7	6.9%	2.3%	4.7%
Antihypertensive agents	47.3	54.1	56.5	14.4%	4.5%	9.7%
Antilipidemics	40.4	47.7	51.6	17.9%	8.3%	13.8%
Total defined daily doses (DDDs)
Antidiabetics, oral	30,812,616	31,491,306	34,798,400	2.2%	10.5%	6.5%
Antihypertensive agents	68,072,912	71,763,792	81,034,536	5.4%	12.9%	9.5%
Antilipidemics	21,945,368	23,592,838	25,791,900	7.5%	9.3%	8.8%
DDDs per drug recipient
Antidiabetics, oral	417.7	386.0	399.1	-7.6%	3.4%	-2.2%
Antihypertensive agents	488.6	425.9	435.0	-12.8%	2.1%	-5.5%
Antilipidemics	184.1	158.8	151.5	-13.8%	-4.6%	-8.9%

FY, fiscal year